Edwards Lifesciences Weighted Average Shares Diluted Trend

EW -- USA Stock  

USD 149.00  2.32  1.58%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Weighted Average Shares Diluted of Edwards Lifesciences Corporation with missing and latest data points interpolated. The weighted average number of shares or units issued and outstanding that are used by the company to calculate [EPSDil]
Weighted Average Shares Diluted10 Years Trend
Slightly volatile
 Weighted Average Shares Diluted 

Regression Statistics

Arithmetic Mean  229,489,912
Geometric Mean  229,328,071
Coefficient Of Variation  3.90
Mean Deviation  7,824,927
Median  235,000,000
Standard Deviation  8,955,562
Range  21,800,000
R Value (0.74)
R Squared  0.55
Significance  0.005893
Slope (1,838,922)

Edwards Lifesciences Weighted Average Shares Diluted Over Time

2016-12-31  217,800,000 
2017-12-31  217,800,000 
2018-12-31  230,578,947 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Edwards Lifesciences Upcoming Company Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.